A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)

NCT03172494 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

720

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: Insulin degludec/liraglutide
DRUG: Insulin degludec
DRUG: Liraglutide

Sponsor

Novo Nordisk A/S